Ep Biocomposites Ltd Stock Price Today (NSE: EPBIO)

Ep Biocomposites Ltd

94.5516.45 (14.82%)
Market Closed

Fundamental Score

...

Ep Biocomposites Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Ep Biocomposites Ltd share price today is 94.55, down 14.82% on NSE/BSE as of 7 August 2026. Ep Biocomposites Ltd (EPBIO) is a Small-cap company in the Waste Management sector with a market capitalisation of 18.70 (Cr). The 52-week high for EPBIO share price is 149.90 and the 52-week low is 75.50. At a P/E ratio of 12.81x, EPBIO is currently trading below its industry average P/E of 27.04x. The company has a Return on Equity (ROE) of 12.90% and a debt-to-equity ratio of 0.20.

Ep Biocomposites Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
112.00
Low
81.90
Volume
717.3913043478261
Change
+7.07%

Ep Biocomposites Ltd share price chart: 7.07% return over the past month. 52-week high ₹149.90, 52-week low ₹75.50.

Ep Biocomposites Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
94.5594.5594.5594.551.00K (Cr)
111.00111.00111.00111.000.00 (Cr)
111.00111.00111.00111.000.00 (Cr)
111.00111.00111.00111.000.00 (Cr)
119.60119.60111.00111.001.00K (Cr)
106.00106.00106.00106.000.00 (Cr)
108.00108.00106.00106.001.50K (Cr)
112.00112.0092.0597.012.00K (Cr)
88.20105.4588.15105.453.00K (Cr)
98.5198.5198.5198.510.00 (Cr)

Ep Biocomposites Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
119.60119.6094.5594.55-20.94%
99.00112.0081.90106.00+7.07%
103.00105.3583.0099.00-3.88%
103.95112.9584.00109.00+4.86%
87.90104.4583.27101.00+14.90%
99.90107.9075.5084.00-15.92%
98.00106.8590.0090.50-7.65%
93.00102.9090.0098.00+5.38%
100.00108.1590.00104.00+4.00%
131.50131.5090.50105.75-19.58%
120.00149.90110.00130.00+8.33%
132.50136.90115.00127.95-3.43%

AI Research Briefing

Powered by Gemini · 2026-08-01

Micro-cap ESG nano-play showing real FY26 earnings growth (+41.5% PAT) but trapped in extreme SME illiquidity and negative 5-year free cash flow.

Research Confidence
5.0/10Moderate
MICRO-CAP DARK HORSEConsolidation with positive medium-term trend — 1M at 5.56%, 3M at 20.88%, 6M at 23.5%.Cheap relative to industry — trades at P/E of 12.81x versus Industry P/E of 27.04x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

No major short-term news catalysts found in the past 4 weeks. Recent company triggers include audited FY26 results showing full-year revenue of ₹13.64 Cr (+13.6% YoY), EBITDA of ₹2.38 Cr (+26% YoY), and PAT of ₹1.46 Cr (+41.5% YoY). Quarterly net profit surged 65.06% YoY alongside a ₹2.15 Cr order win in wastewater solutions.

CORE STORY (THE REAL GAME)

Micro-cap environmental engineering play benefiting from India's Solid Waste Management Rules 2026. This is not a high-tech bio-tech firm; it is a specialized manufacturer of Fibre Reinforced Polymer (FRP) bio-digester toilets, sewage treatment plants (STP), and effluent treatment plants (ETP). The real story is whether municipal mandates force bulk waste generators to buy decentralized waste products from niche regional suppliers.

Why Now
  • FY26 PAT jumped 41.5% YoY to ₹1.46 Cr on ₹13.64 Cr revenue.
  • India introduced SWM Rules 2026 mandating bulk waste generators to process waste at source.
  • Secured ₹2.15 Cr order contract in waste treatment.
Potential Catalysts
  • Inflow of large municipal STP/ETP order wins.
  • Sustainment of 25%+ quarterly top-line revenue growth.
  • Conversion of reported EBITDA into positive operating cash flow.
Key Risks
  • Micro/SME cap illiquidity risk — low trading volumes create severe entry and exit friction.
  • Negative 5-year Free Cash Flow of ₹-6.13 Cr indicating paper profits without cash generation.
  • Zero institutional holding (0% FII, 0% DII) leaving stock entirely to promoter and retail operator dynamics.
Institutional Activity

FII holding stands at 0.0% (Δ 0.0%) and DII at 0.0% (Δ 0.0%). Promoter holds 70.08% with zero pledged shares, but institutional sponsorship is completely absent.

Macro Context

India's Solid Waste Management Rules 2026 mandate bulk generators to process waste on-site, creating demand for local bio-digester and STP suppliers.

Order Book / Expansion

Secured ₹2.15 Cr order contract in waste treatment and deployed IPO proceeds toward capacity expansion.

Cash Flow Quality

Poor — 5Y Free Cash Flow is negative at ₹-6.13 Cr despite ₹1.46 Cr FY26 PAT.

3–6 Month Outlook

Policy-driven top-line momentum expected from waste mandates, but valuation re-rating remains capped until cash flow conversion improves.

Primary Thesis Risk

Negative free cash flow paired with SME micro-cap illiquidity makes exit impossible during sell-offs.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

12.90%

Profit generated per ₹1 of shareholder equity

Average

Return on Capital (ROCE)

16.27%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

14.93%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Ep Biocomposites Ltd Valuation Check

Excellent

Price to Earnings (P/E)

12.81x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

27.04x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

70.08%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

65.06%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

25.92%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

35.83%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-34.50%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

32.32%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.20x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

6.71x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-6.13 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Ep Biocomposites Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of EPBIO across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Excellent ROCE Performance (16.27%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 12.81 vs Industry: 27.04)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (65.06%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (25.92%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (35.83% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (32.32% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.20)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (6.71x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (70.08%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Weak Earnings Growth (-34.50% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-6.13 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Ep Biocomposites Ltd vs Waste Management Peers

Peer Comparison - Waste Management

Compare Ep Biocomposites Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
70/100
95
₹18.70
12.8
Average
12.90%
Average
16.27%
Good
0.2
Excellent
32.32%
Excellent
35.83%
Excellent
0.00%
EMS Ltd...
EMSLIMITED543983
19/100
412
₹2447.58
27.0
Average
8.91%
Poor
12.51%
Average
0.1
Excellent
4.72%
Average
17.25%
Excellent
0.34%
54.1/100
427
₹1294.27
17.1
Average
10.79%
Average
11.16%
Average
0.6
Good
10.86%
Good
17.76%
Excellent
0.00%
69.7/100
499
₹1019.26
44.1
Average
23.29%
Excellent
29.97%
Excellent
0.1
Excellent
99.04%
Excellent
30.62%
Excellent
0.00%
50.1/100
371
₹870.33
30.4
Average
26.21%
Excellent
29.26%
Excellent
0.3
Excellent
66.45%
Excellent
35.94%
Excellent
0.00%
71.9/100
517
₹816.42
22.8
Average
18.17%
Good
19.76%
Good
0.3
Excellent
125.87%
Excellent
47.03%
Excellent
0.00%
28.9/100
288
₹660.00
28.9
Average
4.13%
Poor
6.63%
Poor
0.3
Excellent
2.85%
Average
9.92%
Good
0.00%
43.1/100
274
₹656.30
45.7
Average
14.95%
Average
21.33%
Excellent
0.0
Excellent
0.00%
37.5/100
122
₹347.33
11.6
Average
14.05%
Average
18.88%
Good
0.8
Good
416.82%
Excellent
22.62%
Excellent
0.00%
18.6/100
139
₹346.61
65.7
Average
5.98%
Poor
10.41%
Average
0.7
Good
0.00%
71.6/100
229
₹239.08
9.5
Average
19.42%
Good
15.86%
Good
0.4
Excellent
49.97%
Excellent
53.03%
Excellent
0.00%

Ep Biocomposites Ltd PE Ratio History

Historical price-to-earnings ratio for EPBIO — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20246.84₹172.6025.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Ep Biocomposites Ltd Quarterly Performance

Latest quarterly metrics for EPBIO — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

25.92%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

65.06%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

35.83%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

32.32%

Compounded annual net profit growth over 5 years

Ep Biocomposites Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for EPBIO — calculated from daily price history

56RSI 14
Neutral — RSI 56

Momentum is balanced — neither overbought nor oversold.

SMA 50
99
▼ Price below SMA 50 — Short-term bearish
SMA 200
109
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
1K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Ep Biocomposites Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Ep Biocomposites Ltd (EPBIO) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Ep Biocomposites Ltd

About EPBIO (Ep Biocomposites Ltd)

EP Biocomposites Ltd is at the forefront of revolutionizing waste management through innovative and sustainable solutions. The company specializes in the development and deployment... of advanced bio-digester toilets, offering a hygienic and environmentally conscious alternative to traditional sanitation methods. These systems effectively break down organic waste, significantly reducing environmental impact and promoting cleaner and healthier communities. Complementing this, their range of sewage and effluent treatment plants leverage cutting-edge technologies to purify wastewater, enabling its safe reuse and minimizing pollution of vital water resources. EP Biocomposites is committed to transforming the landscape of waste management, fostering a circular economy, and ensuring a cleaner, more sustainable future for all. Beyond waste treatment infrastructure, EP Biocomposites Ltd. utilizes the strength and versatility of fiber-reinforced polymer (FRP) in a range of applications that support responsible waste handling. Their durable FRP dustbins are designed to withstand harsh conditions, promoting efficient waste collection in public spaces. The company's FRP roof tiles and decorative elements, crafted from sustainable materials, offer aesthetic appeal and contribute to eco-friendly construction practices. By integrating sustainable materials and designs into everyday products, EP Biocomposites promotes a holistic approach to waste reduction and resource conservation. EP Biocomposites Ltd.’s unwavering commitment to innovation extends beyond its core product lines. They are dedicated to continuous research and development, exploring new ways to harness the power of biocomposites in waste management and related fields. By fostering collaboration with researchers and industry partners, they stay at the cutting edge of sustainable technology, constantly refining their solutions and expanding their portfolio to meet the evolving needs of a world increasingly focused on environmental responsibility. Their dedication positions them as a key player in shaping the future of waste management.

Company Details

Symbol:EPBIO
Industry:Waste Management
Sector:Waste Management

Key Leadership

Mr. Rajkumar Gajanan Kamat
Founder, Chairperson & MD
Ms. Nilam Naresh Kadkade
Chief Financial Officer
Ms. Aanchal Agrawal
Company Secretary & Compliance Officer

EPBIO Share Price: Frequently Asked Questions

What is the current share price of Ep Biocomposites Ltd?

Ep Biocomposites Ltd (EPBIO) trades at ₹94.55 on NSE and BSE. Market cap ₹18.70 (Cr). Educational data only.

What is the P/E ratio of Ep Biocomposites Ltd?

Ep Biocomposites Ltd has a P/E of 12.81x vs industry average 27.04x.

What is the Bull Run score for Ep Biocomposites Ltd?

Ep Biocomposites Ltd has a Bull Run score of 70/100 based on 25+ financial parameters.

Does Ep Biocomposites Ltd pay dividends?

Ep Biocomposites Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Ep Biocomposites Ltd?

Ep Biocomposites Ltd has ROE of 12.90%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Ep Biocomposites Ltd?

Ep Biocomposites Ltd has debt-to-equity of 0.20.

Is Ep Biocomposites Ltd a good investment?

Bull Run gives Ep Biocomposites Ltd a score of 70/100. This is not investment advice — consult a SEBI-registered advisor.